Evoke Pharma Inc (EVOK)
Official siteDRUG MANUFACTURERS - SPECIALTY & GENERIC
Last updated: Dec 17, 2025 at 4:00 PM ET
Earnings
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 29.2% above its 50-day moving average. The 14-day RSI is 85.2, above 70, the overbought line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about EVOK
News
No news available
Company news will appear here when available
Evoke Pharma Competitors
Peers by sector and size for Evoke Pharma (EVOK) include Galecto, Rockwell Medical and Sangamo Therapeutics.
Sector: Healthcare
EVOK Bull Case vs Bear Case
Bear case
- EVOK beat EPS estimates in 12.5% of its last 8 reported quarters.
EVOK Earnings: Beat Rate
- Beat rate
- 1 of 8 quarters (12.5%)
- Average surprise
- -44.9%
EVOK Earnings Call
The latest EVOK earnings call transcript on file is labeled 2024Q4.
Read the 2024Q4 transcriptUpdated Nov 13, 2025. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About EVOK
Does EVOK pay dividends?
Evoke Pharma Inc (EVOK) does not currently pay a regular dividend.
EVOK pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.